PHARMA MAR, S.A. desde 16/05/2019 hasta 16/05/2019 16/05/2019 07:37 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Abstract information to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) concerning Lurbinectedin Número de registro: 278282 Relacionado con 276625 del 01/04/2019 (08:18)